- Home
- PAVS vs VERU Comparison
PAVS vs VERU Comparison
Compare PAVS & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAVS | VERU |
|---|---|---|
| Founded | 2004 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.1M | 39.8M |
| IPO Year | 2019 | 1990 |
Fundamental Metrics
Financial Performance| Metric | PAVS | VERU |
|---|---|---|
| Price | $0.04 | $2.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 178.5M | 115.8K |
| Earning Date | 08-04-2025 | 12-16-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $12,416,127.00 | ★ $16,886,419.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18037.91 | 337.24 |
| 52 Week Low | $0.03 | $2.11 |
| 52 Week High | $1.50 | $14.20 |
Technical Indicators
Market Signals| Indicator | PAVS | VERU |
|---|---|---|
| Relative Strength Index (RSI) | 31.72 | 47.56 |
| Support Level | $0.03 | $2.33 |
| Resistance Level | $0.07 | $2.51 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | -0.06 | 0.07 |
| Stochastic Oscillator | 1.41 | 83.05 |
Price Performance
Historical ComparisonAbout PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.